EUVIMEDEUVIMED entdecken
Open Access

Early Mitochondrial Defects in the 5xFAD Mouse Model of Alzheimer’s Disease

Neelam Sharma, Rupkatha Banerjee, Ronald L Davis

Journal of Alzheimer's Disease · 2023

DOI: 10.3233/jad-220884 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer's Disease, 2023. Verfasst von Neelam Sharma und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, University of Florida Scripps Biomedical Research Institute, Jupiter, FL, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Mitochondria. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Mitochondrial (MT) dysfunction is a hallmark of Alzheimer’s disease (AD). Amyloid-β protein precursor and amyloid-β peptides localize to MT and lead to MT dysfunction in familial forms of AD. This dysfunction may trigger subsequent types of pathology.

Objective

To identify the MT phenotypes that occur early in order to help understand the cascade of AD pathophysiology.

Methods

The 5xFAD mouse model was used to explore the time course of MT pathologies in both sexes. Protein biomarkers for MT dynamics were measured biochemically and MT function was measured using oxygen consumption and ATP assays.

Results

We discovered progressive alterations in mitochondrial dynamics (biogenesis, fission, fusion, and mitophagy) and function (O2 consumption, ATP generation, and Ca2+ import) in the hippocampus of 5xFAD mice in both sexes as early as 2 months of age. Thus, mitochondrial dynamics and function become altered at young ages, consistent with an early role for mitochondria in the AD pathological cascade.

Conclusion

Our study offers the baseline information required to understand the hierarchical relationship between the multiple pathologies that develop in this mouse model and provides early biomarkers for MT dysfunction. This will aid in dissecting the temporal cascade of pathologies, understanding sex-specific differences, and in testing the efficacy of putative mitochondrial therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseMitochondriaAnimalsFemaleMaleMiceAdenosine TriphosphateAmyloid beta-PeptidesAmyloid beta-Protein PrecursorBiomarkersDisease Models, AnimalMice, Transgenic

Stichwörter der Autor:innen

Alzheimer’s diseaseMT dysfunctionamyloid-β protein precursorbioenergeticsbiogenesisfission/fusionmitophagy

Substanzen

Adenosine TriphosphateAmyloid beta-PeptidesAmyloid beta-Protein PrecursorBiomarkers

Autor:innen und Institutionen

  • Department of Neuroscience, University of Florida Scripps Biomedical Research Institute, Jupiter, FL, USA.

Förderung

  • NIA NIH HHS

Zitieren

APA

Sharma, N., Banerjee, R., & Davis, R. L. (2023). Early Mitochondrial Defects in the 5xFAD Mouse Model of Alzheimer’s Disease. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-220884

Vancouver

Sharma N, Banerjee R, Davis RL. Early Mitochondrial Defects in the 5xFAD Mouse Model of Alzheimer’s Disease. Journal of Alzheimer's Disease. 2023. doi:10.3233/jad-220884

BibTeX
@article{Sharma2023,
  author = {Sharma, Neelam and Banerjee, Rupkatha and Davis, Ronald L},
  title = {Early Mitochondrial Defects in the 5xFAD Mouse Model of Alzheimer’s Disease},
  journal = {Journal of Alzheimer's Disease},
  year = {2023},
  doi = {10.3233/jad-220884}
}
Kostenlos starten →